Skip to main content
. 2019 May 20;8(5):713. doi: 10.3390/jcm8050713

Table 2.

Perioperative characteristics of kidney recipients.

Control Group (n = 83) RIPC Group (n = 85) p-Value
Preoperative characteristics
 Age 45.9 ± 13.4 47.6 ± 10.0 0.34
 Males, n (%) 43 (50.6) 46 (54.1) 0.65
 Body mass index, kg/m2 22.6 ± 3.6 22.8 ± 3.3 0.68
 sCr, mg/dL 7.9 (5.7–9.2) 7.5 (6.0–9.1) 0.53
 eGFR, mL/min/1.73 m2 7.0 (5.0–9.0) 7.0 (5.0–9.0) 0.41
 Duration of chronic renal failure, months 72.9 ± 84.1 70.8 ± 58.4 0.22
 Dialysis, n (%) 67 (78.8) 64 (75.30) 0.58
 Second transplantation, n (%) 9 (10.8) 6 (7.1) 0.39
 ABO incompatibility, n (%) 28 (33.7) 25 (29.4) 0.55
 Hypertension, n (%) 76 (89.4) 70 (82.4) 0.19
 Cerebrovascular accident, n (%) 2 (2.4) 0 (0) 0.50
 Diabetes mellitus, n (%) 18 (21.2) 22 (25.9) 0.47
 Ischemic heart disease, n (%) 4 (4.7) 2 (2.4) 0.68
Intraoperative characteristics
 Duration of operation, min 267.0 (252.0–302.5) 267.0 (230.0–310.0) 0.51
 Plasmalyte, mL 950 (700–1300) 1000 (700–1260) 0.83
 Transfusion of RBC, n (%) 5 (6.0) 3 (3.5) 0.69
 20% Mannitol, mL 150 (125–170) 150 (125–175) 0.85
 Cold ischemic time, min 41.0 (26.5–56.0) 37.0 (22.0–55.0) 0.23
 Warm ischemic time, min 28.0 (24.0–31.0) 25.0 (23.0–29.0) <0.01
Lowest mean blood pressure, mmHg
  Before reperfusion 78.0 (70.0–83.0) 79.3 (71.0–87.3) 0.30
  After reperfusion 84.8 ± 11.4 87.0 ± 11.1 0.20
 Intraoperative inotropic use, n (%) 12 10 0.77
  Dobutamine 6 9 -
  Norepinephrine 6 1 -
 Urine output, mL 430 (260–745) 440 (300–680) 0.80

RIPC, remote ischemic preconditioning; sCr, serum creatinine; eGFR, estimated glomerular filtration rate based on the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation; ABO incompatibility, ABO incompatibility between recipients and donors; RBC, red blood cells. Data are expressed as mean ± standard deviation (SD), median and interquartile range, or number (%), as appropriate.